VESSEL

sulodexide

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VESSEL, covering 2024-07-31 to 2024-07-31. Get the full timeline:

Most recent: Clinical Trial Update: Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study) [Phase 3]